Emery Shannon L, Erdman Dean D, Bowen Michael D, Newton Bruce R, Winchell Jonas M, Meyer Richard F, Tong Suxiang, Cook Byron T, Holloway Brian P, McCaustland Karen A, Rota Paul A, Bankamp Bettina, Lowe Luis E, Ksiazek Tom G, Bellini William J, Anderson Larry J
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Emerg Infect Dis. 2004 Feb;10(2):311-6. doi: 10.3201/eid1002.030759.
A real-time reverse transcription-polymerase chain reaction (RT-PCR) assay was developed to rapidly detect the severe acute respiratory syndrome-associated coronavirus (SARS-CoV). The assay, based on multiple primer and probe sets located in different regions of the SARS-CoV genome, could discriminate SARS-CoV from other human and animal coronaviruses with a potential detection limit of <10 genomic copies per reaction. The real-time RT-PCR assay was more sensitive than a conventional RT-PCR assay or culture isolation and proved suitable to detect SARS-CoV in clinical specimens. Application of this assay will aid in diagnosing SARS-CoV infection.
开发了一种实时逆转录-聚合酶链反应(RT-PCR)检测方法,用于快速检测严重急性呼吸综合征相关冠状病毒(SARS-CoV)。该检测方法基于位于SARS-CoV基因组不同区域的多个引物和探针组,能够将SARS-CoV与其他人类和动物冠状病毒区分开来,每个反应的潜在检测限<10个基因组拷贝。实时RT-PCR检测方法比传统RT-PCR检测方法或培养分离法更灵敏,证明适用于检测临床标本中的SARS-CoV。该检测方法的应用将有助于诊断SARS-CoV感染。